NARI250117P70000
- 0.04
- -0.01-20.00%
Inari Medical Newsroom
Analysts Offer Insights on Healthcare Companies: Cencora (COR) and Inari Medical (NARI)
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $80 to $80
Inari Medical Analyst Ratings
Hold Rating Issued for Inari Medical Amidst Stryker Acquisition With Minimal Antitrust Concerns and Reasonable Valuation
Jefferies Downgrades Inari Medical to Hold From Buy, $80 Price Target
Inari Medical Is Maintained at Neutral by Piper Sandler
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $80
Inari Medical Cut to Hold From Buy by Canaccord Genuity
Inari Medical Analyst Ratings
Baird Downgrades Inari Medical to Neutral, Lowers Price Target to $80
Stryker's Strategic Acquisition of Inari Medical Leads to Hold Rating Amid Premium Valuation
Bank of America Securities Keeps Their Buy Rating on Inari Medical (NARI)
Cautious Hold: Evaluating Inari Medical's Acquisition by Stryker Amidst Growth Deceleration and Market Uncertainties
Truist Securities Raises Price Target on Inari Medical to $63 From $50, Keeps Hold Rating
Inari Medical Analyst Ratings
Oppenheimer Initiates Coverage On Inari Medical With Outperform Rating, Announces Price Target of $75
Truist Financial Maintains Inari Medical(NARI.US) With Hold Rating, Maintains Target Price $50
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $74
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $48 to $86
Truist Raises Price Target on Inari Medical to $50 From $46, Keeps Hold Rating